BLIS Technologies Ltd
NZX:BLT

Watchlist Manager
BLIS Technologies Ltd Logo
BLIS Technologies Ltd
NZX:BLT
Watchlist
Price: 0.019 NZD Market Closed
Market Cap: 24.3m NZD

Operating Margin
BLIS Technologies Ltd

3.9%
Current
-4%
Average
6.6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
3.9%
=
Operating Profit
490k
/
Revenue
12.6m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
NZ
BLIS Technologies Ltd
NZX:BLT
24.3m NZD
4%
US
Eli Lilly and Co
NYSE:LLY
734.3B USD
40%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
401.6B USD
26%
DK
Novo Nordisk A/S
CSE:NOVO B
1.9T DKK
45%
CH
Roche Holding AG
SIX:ROG
202.1B CHF
33%
CH
Novartis AG
SIX:NOVN
178B CHF
33%
UK
AstraZeneca PLC
LSE:AZN
160.5B GBP
24%
US
Merck & Co Inc
NYSE:MRK
205B USD
34%
IE
Endo International PLC
LSE:0Y5F
183.8B USD
11%
US
Pfizer Inc
NYSE:PFE
141.6B USD
27%

BLIS Technologies Ltd
Glance View

Market Cap
24.3m NZD
Industry
Pharmaceuticals

BLIS Technologies Ltd. engages in the development of healthcare products based on strains of bacteria that produce Bacteriocin activity. The company is headquartered in Dunedin, Otago. The company went IPO on 2001-07-30. The firm is also engaged in supply of healthcare ingredients and the manufacture of part and finished goods and food products for sale in domestic and international markets. The firm supplies BLIS-branded finished goods. The firm's products include BLIS K12 and BLIS M18, which are oral probiotics providing protection for ear, nose and throat health, halitosis (bad breath), gums and teeth health and immune support. The firm distributes its products through Stratum Nutrition in North America, NZPR Group in China, and Bluestone Pharma in Europe and Middle East. Its other BLIS branded products include Throat Guard EVERYDAY BLIS K12, Travel Guard BLIS K12, Fresh Breath Kit K12 and Toddler Protect BLIS K12 Powder for Toddlers.

BLT Intrinsic Value
0.007 NZD
Overvaluation 62%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
3.9%
=
Operating Profit
490k
/
Revenue
12.6m
What is the Operating Margin of BLIS Technologies Ltd?

Based on BLIS Technologies Ltd's most recent financial statements, the company has Operating Margin of 3.9%.

Back to Top